Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 47 | 0 | 5 | 0 | €700.30 | €755.83 | 7.930% |
| Boston Scientific | 37 | 0 | 4 | 0 | €63.50 | €61.53 | -3.109% |
| Vertex Pharmaceuticals Inc. | 39 | 2 | 4 | 0 | €369.35 | €382.71 | 3.616% |
| Intuitive Surgical Inc | 35 | 0 | 3 | 0 | €359.50 | €368.20 | 2.420% |
| UnitedHealth Group Inc. | 33 | 1 | 7 | 0 | €464.30 | €543.72 | 17.105% |
| Regeneron Pharmaceuticals Inc. | 31 | 1 | 5 | 1 | €841.80 | €954.29 | 13.364% |
| Merck & Co. Inc. | 27 | 1 | 4 | 0 | €117.00 | €124.92 | 6.765% |
| Thermo Fisher Scientific Inc. | 24 | 0 | 3 | 0 | €507.60 | €561.51 | 10.620% |
| Edwards Lifesciences Corp. | 24 | 1 | 4 | 0 | €80.60 | €87.81 | 8.941% |
| Amgen Inc. | 23 | 0 | 3 | 0 | €248.95 | €293.65 | 17.954% |
| Humana Inc. | 20 | 0 | 3 | 0 | €306.90 | €473.29 | 54.215% |
| HCA Holdings Inc. | 19 | 0 | 2 | 0 | €280.10 | €289.08 | 3.204% |
| BioMarin Pharmaceutical Inc. | 18 | 0 | 0 | 0 | €84.64 | €102.48 | 21.073% |
| AbbVie Inc. | 18 | 1 | 3 | 1 | €153.72 | €175.79 | 14.356% |
| Dexcom Inc. | 17 | 0 | 2 | 0 | €124.56 | €136.81 | 9.835% |
| Stryker Corp. | 17 | 0 | 4 | 0 | €305.90 | €331.52 | 8.377% |
| Resmed Inc. | 16 | 0 | 2 | 0 | €165.65 | €184.33 | 11.280% |
| Abbott Laboratories | 17 | 1 | 2 | 0 | €98.92 | €116.71 | 17.987% |
| Cigna Corp. | 15 | 0 | 1 | 0 | €327.40 | €342.03 | 4.468% |
| Agilent Technologies Inc. | 17 | 3 | 2 | 1 | €123.32 | €133.66 | 8.385% |
| Hologic Inc. | 13 | 0 | 2 | 0 | €71.00 | €84.03 | 18.355% |
| Centene Corp. | 13 | 0 | 5 | 0 | €69.30 | €82.26 | 18.695% |
| Exact Sciences | 11 | 0 | 1 | 0 | €59.64 | €83.49 | 39.998% |
| Teleflex Inc. | 10 | 0 | 0 | 0 | €208.00 | €247.18 | 18.836% |
| Henry Schein Inc. | 11 | 1 | 0 | 0 | €66.56 | €79.30 | 19.142% |